Work

PP65 PIK3CA mutations in patients with advanced cancers treated in a phase I clinic

Year: 2009

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(09)72172-x

Authors: F. Janku, D.S. Hong, A.M. Tsimberidou, A. Naing, G.S. Falchook, J.J. Wheler, S.L. Moulder, R. Kurzrock

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1998342928

Cites:

Cited by:

Related to: 10